StreetAlpha.app
Home › Stocks › TAK

Takeda Pharmaceutical Co Ltd (TAK)

Healthcare
$21.77
▲ +1.68%
LAST CLOSE · NOV 20

Takeda makes and sells branded prescription medicines, selling to hospitals, insurers and government health programs in Japan, the U.S. and Europe. It last closed at $21.77 on Nov 20, up 1.68% on the day. Over the last 12 months TAK insiders bought $0 of stock on the open market and sold $15.2M, according to SEC Form 4 filings.

AI Auto Pilots
Is TAK in one of our AI portfolios?
Five AI traders run real portfolios in the open, with every decision logged. Create a free account to see if they hold TAK.

Key Stats

Fiscal 2025
Results
Revenue
JPY 4.58T
+7.5% vs a year ago
Net income
JPY 108B
−25.1% vs a year ago
Free cash flow
JPY 856B
18.7% margin
Operating margin
7.5%
JPY 343B operating income
Balance sheet
Cash & equivalents
JPY 385B
At Mar 31
Debt
JPY 4.52T
At Mar 31
Shareholder equity
JPY 6.94T
ExchangeNYSE
Financials history
FY2021: JPY 3.20TJPY 3.20TFY2021FY2022: JPY 3.57TJPY 3.57TFY2022FY2023: JPY 4.03TJPY 4.03TFY2023FY2024: JPY 4.26TJPY 4.26TFY2024FY2025: JPY 4.58TJPY 4.58TFY2025

From TAK's SEC filings, latest 20-F for the period ending Mar 31, 2025 (filed Jun 17). Figures are in JPY. Per share figures are left out because the US listing can represent a different number of shares.

Next report
—
No date on the calendar yet
Consensus EPS forecast
EPS and revenue estimates
Year-ago EPS
Same quarter last year
Options-implied move
Move priced in by options
Analyst consensus
Ratings from the last 90 days
Loading…

Technical Analysis

TAK · as of the Nov 20 close · updated each morning
Uptrend, nearing overbought

The stock is 4% above its 20 day and 9% above its 50 day average. It is 18% above its 200 day average, so the longer trend is still up. Momentum is improving (RSI 69), near overbought. The nearest support is the Pivot S1 at $21.65, and the nearest resistance the swing high (Nov 16) at $21.86.

Short trendBullish
Long trendBullish
MomentumImproving
StretchNear overbought
VolatilityNormal, 2.0%/day
Key levels
$22.0752 week high+1.4%
$21.98Pivot R1+1.0%
$21.86Pivot+0.4%
$21.86Swing high (Nov 16)+0.4%
$21.77Last close
$21.65Pivot S1−0.6%
$20.9920 day average−3.6%
$20.57Swing low (Nov 6)−5.5%
$19.7250 day average−9.4%
$18.60100 day average−14.6%
$17.88200 day average−17.9%
$14.0152 week low−35.6%
Indicators
RSI (14)69.33Strong, overbought above 70Neutral
MACD0.54Below its signal lineBearish
Stochastic66.7Middle of its rangeNeutral
ADX (14)32.5Trending up
Williams %R-19.8Oversold below −80, overbought above −20Overbought
CCI (20)141.2Oversold below −100, overbought above 100Overbought
Rate of change+3.6%Change over 10 sessionsBullish
ATR (14)$0.43Typical daily range, 2.0% of price
MA 10Above
MA 20Above
MA 50Above
MA 100Above
MA 200Above
What happened before, for TAK

What happened before

See how TAK did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record. Free with an account.

November seasonalityHow TAK usually does this month. See Seasonality

Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.

AI Day Trader
Watch Claude day trade the open, live.
Every session it trades SPY, QQQ, IWM and two daily stock picks, with each call logged before the move.

Seasonality

How TAK has done in each calendar month: the average and median return, how often each month finished higher, and every year since 2018.

Loading…

See the stocks that usually rise in November →

Whale Options Flow

90D
Whale options flow for TAKHow many large options trades hit TAK, the bullish and bearish split, and every trade with strike, premium and expiry are shown to AI Starter and AI Pro members.Sign up freeSign in

See today’s whale options flow across the market →

TAK Institutional Ownership

Full report →
Fund sentiment · Q3 2026
Strongly bullish
Strongly bearishNeutralStrongly bullish
  • ▲236 buying vs 130 selling
  • ▲Shares held by funds +18.2%
  • ▲Funds holding +19
  • ▲Superinvestors: 4 added, 1 cut
  • ●Put/call not meaningful
Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Funds holding
Q3 2026This quarterLast quarterChange
Funds holding400381+5.0%
In funds' top 1021+100.0%
Held by funds–––
New / increased60 / 17661 / 147+13.5%
Reduced / sold out90 / 40100 / 42−8.5%
Put/call ratio0.080.31−72.7%
Top holders, biggest buyers and sellers, 8 quarters of charts and this season's filings so far.See TAK institutional ownership →

From SEC Form 13F filings for Sep 30, 2026. What the filings show, not a forecast: positions can be up to 45 days old and leave out short sales.

TAK Insider Trading

All filings →
Insider trading · 12 months
Insiders are only selling
Bought$00 buys · 0 insiders
Sold$15.2M21 sales · 13 insiders
16% of the selling was under pre-arranged trading plans.
2026-08 sold $10.3M2026-09 sold $2.8M2026-11 sold $2.1MDecMarJunSep
BoughtSoldlast 12 months
Trade dateInsiderTypeSharesPriceValue
Nov 4Giles Richard PlatfordPresident, IBUSale55,617$20.90$1.2M
Nov 2Teresa Marie BitettiPresident, OBUSale46,609$20.89$974K
Sep 14Lauren Rusckowski DupreyChief Transformation OfficerSale34,535$18.54$640K
Sep 2Andrew Stewart PlumpPresident, R&DSale plan116,191$18.49$2.1M
Aug 19Andrew Stewart PlumpPresident, R&DSale plan19,651$18.49$363K
Aug 18Nicola Deidre Petal GreenwayChief Human Resources OfficerSale12,980$18.11$235K
Every insider buy and sale for TAK over 2 years, with a link to each SEC filing. AI Pro members can get an alert the moment an insider trades.See TAK insider trades →

From SEC Form 4 filings by TAK's officers, directors and 10% owners. Open market buys and sales only; option exercises, gifts, awards and tax withholding are left out. Not investment advice.

AI Auto Pilots

Paper trading

StreetAlpha runs autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether TAK is in one of them and how their past TAK trades turned out.

TAK in the AI portfolios
Loading…

TAK News Tone and Price

Loading…

Macro & Market News

All StreetAlpha news →

StreetAlpha hasn't covered TAK in an article yet. Here's the latest on the wider market.

TAK in the news

TAK Congress Trades

All congress trades →
Trades, 12 months
1
Buys
1
100%
Sells
0
0%
People
1
Last filed Nov 5
Who traded TAK · since 2018
Latest 5 filings of 9
$1K – $15KTraded Oct 9, 2026Filed Nov 5, 2026
$15K – $50KTraded Aug 29, 2023Filed Sep 5, 2023
$15K – $50KTraded Jul 10, 2023Filed Aug 13, 2023
$1K – $15KTraded Feb 27, 2023Filed Mar 20, 2023
$1K – $15KTraded Feb 16, 2023Filed Mar 3, 2023
PersonTypeAmountTradedFiledDelay
Ro KhannaD · CABuy$1K – $15KOct 9, 2026Nov 5, 202627 d
Virginia FoxxR · NCSell$15K – $50KAug 29, 2023Sep 5, 20237 d
Dan GoldmanD · NYSell$15K – $50KJul 10, 2023Aug 13, 202334 d
Dan GoldmanD · NYBuy$1K – $15KFeb 27, 2023Mar 20, 202321 d
Virginia FoxxR · NCBuy$1K – $15KFeb 16, 2023Mar 3, 202315 d

From official House and Senate disclosure reports, filed up to 45 days after the trade and shown in dollar ranges. Not investment advice. Use limited by 5 U.S.C. 13107. About this data

About Takeda Pharmaceutical Co

Takeda is a pharmaceutical company based in Tokyo, Japan, that makes and sells branded prescription medicines. Its products are sold in the United States, Europe, Japan and emerging markets such as China. Its customers include hospitals and medical institutions, insurers and managed care groups, pharmacy benefit managers, and government health programs. Its products face price pressure and competition from generic and biosimilar versions once patent or regulatory protection ends.

Headquarters
Tokyo, Japan